Neuren drug finally been cleared by FDA in USA

SYDNEY: Australia’s top performing health stock for 2022, Neuren, has gained clearance from ... read more

Mesoblast shares surge on FDA filing in USA

SYDNEY: Mesoblast chief executive Silviu Itescu says a more than 12 per cent ... read more

Ebos gets boost with inclusion in prestigious MSCI index

WELLINGTON: Ebos Group, Australasia’s largest distributor of healthcare and medical products, energised the ... read more

Pharmaco expands portfolio with acquisition of Oraltec

AUCKLAND: New Zealand-owned healthcare company Pharmaco (N.Z.) Ltd today announces its continued growth ... read more